BRCA2 and posterior cortical atrophy: In our study, the three PCa patients carrying heterozygous BRCA2 germline mutations were treated with ADT combined with radiotherapy or chemotherapy, both primary lesions and metastases shrunk significantly, and their PSA levels were well controlled.